Intuitive Surgical crushed Q2 with EPS of $2.80, an 11.8% beat on consensus and its fifth straight quarter topping expectations, as da Vinci 5 adoption surged to 246 placements and gross margins expanded despite tariff headwinds that spooked investors earlier this year.
Intuitive Surgical :
ISRG
ISRG
Stock Data
$350.93
$5.51 (1.59%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL INSTRUMENTS & SUPPLIES
Intuitive Surgical Inc is a pioneer in the field of robotic-assisted, minimally invasive surgery. With its flagship product, the da Vinci Surgical System, the company has revolutionized complex surgeries by making them less invasive, which often leads to quicker patient recovery times. Beyond surgery, its Ion endoluminal system offers minimally invasive diagnostic procedures, particularly for lung biopsies. Intuitive Surgical not only manufactures and markets these innovative systems but also supports their integration into healthcare settings with comprehensive training, maintenance, and digital solutions. Founded in 1995, the company is based in Sunnyvale, California, and operates globally.
Latest Activity
Intuitive Surgical reports Q2 earnings after the close at 4:38 PM ET, with the da Vinci 5 rollout and procedure volumes front and center for investors.
All Intuitive Surgical Articles
161 Articles